Literature DB >> 31185099

Dissatisfaction After Trifocal IOL Implantation and Its Improvement by Selective Wavefront-Guided LASIK.

Theo G Seiler, Aharon Wegner, Tim Senfft, Theo Seiler.   

Abstract

PURPOSE: To evaluate a substantially improved wavefront acquisition technique (Peramis; SCHWIND eye-tech-solutions, Kleinostheim, Germany) for selective wavefront-guided aberration correction to improve satisfaction after implantation of trifocal intraocular lenses (IOLs).
METHODS: Of 213 eyes from 108 consecutive patients receiving cataract surgery with multifocal IOL implantation (FineVision; PhysIOL, Liége, Belgium), 56 eyes (26%) of 42 dissatisfied patients were treated with selective wavefront-guided laser in situ keratomileusis (LASIK) (Amaris 1050; SCHWIND eye-tech-solutions) free of cost with a follow-up of 12 months. Selective wavefront-guided ablation corrected for all aberrations except spherical aberrations to preserve the apodization and therefore to enhance the multifocal effect. The degree of satisfaction after trifocal IOL implantation, its increase after selective wavefront-guided LASIK, and the refractive error (spherical equivalent, refractive astigmatism) before and after selective wavefront-guided LASIK were evaluated.
RESULTS: Refractive astigmatism of greater than 0.50 diopters (D) was the most frequent residual refractive error (63%), followed by myopia (45%), hyperopia (20%), and increased ocular higher order aberrations (13%). After selective wavefront-guided LASIK, the refractive target (±0.50 D) was achieved in 98% and refractive astigmatism was 0.50 D or less in 93% of the eyes operated on. The overall satisfaction score in dissatisfied patients increased from 2.1 ± 0.8 preoperatively to 3.6 ± 0.8 (out of 4). Eighty-eight percent of initially dissatisfied patients would choose this procedure again.
CONCLUSIONS: Selective wavefront-guided LASIK reduced refractive errors and significantly increased spectacle independence and satisfaction, which may lead to a better acceptance of trifocal IOLs. [J Refract Surg. 2019;35(6):346-352.]. Copyright 2019, SLACK Incorporated.

Entities:  

Mesh:

Year:  2019        PMID: 31185099     DOI: 10.3928/1081597X-20190510-02

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  9 in total

1.  SMILE for the Treatment of Residual Refractive Error After Cataract Surgery.

Authors:  Faruk Semiz; Anita Syla Lokaj; Njomza Hima Musa; Ceren Ece Semiz; Zekeriya Alp Demirsoy; Olcay Semiz
Journal:  Ophthalmol Ther       Date:  2022-05-28

2.  A prospective pilot study using a low power piggy-back toric implantable Collamer lens to correct residual refractive error after multifocal IOL implantation.

Authors:  Gernot Iw Duncker; Anna C Sasse; Tobias Duncker
Journal:  Clin Ophthalmol       Date:  2019-09-03

3.  The Vivity Extended Range of Vision IOL vs the PanOptix Trifocal, ReStor 2.5 Active Focus and ReStor 3.0 Multifocal Lenses: A Comparison of Patient Satisfaction, Visual Disturbances, and Spectacle Independence.

Authors:  John A Hovanesian; Michael Jones; Quentin Allen
Journal:  Clin Ophthalmol       Date:  2022-01-18

4.  Perception of Trifocal IOL Performance in Young Adults with High Astigmatism and Hyperopia and its Improvement Using Small Incision Lenticule Extraction.

Authors:  Faruk Semiz; Anita Syla Lokaj; Gulser Caliskan; Giuseppe Verlato; Njomza Hima Musa; Ceren Ece Semiz; Zekeriya Alp Demirsoy
Journal:  Acta Inform Med       Date:  2021-06

5.  Vision-related Quality of Life after Bilateral Implantation of Monofocal and Multifocal Intraocular Lenses.

Authors:  Shahram Bamdad; Seyyed Ahmad Razavizadegan; Mohsen Farvardin; Sahar Mohaghegh
Journal:  J Ophthalmic Vis Res       Date:  2022-01-21

6.  Patients' dissatisfaction with multifocal intraocular lenses managed by exchange with other multifocal lenses of different optical profiles.

Authors:  Olena Al-Shymali; Colm McAlinden; Jorge L Alio Del Barrio; Mario Canto-Cerdan; Jorge L Alio
Journal:  Eye Vis (Lond)       Date:  2022-03-01

7.  Monofocal intraocular lens with enhanced intermediate function as substitute for multifocal intraocular lens in positive dysphotopsia.

Authors:  Tadas Naujokaitis; Ling Zhao; Debora Scharf; Ramin Khoramnia; Gerd U Auffarth
Journal:  Am J Ophthalmol Case Rep       Date:  2022-04-10

8.  A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances.

Authors:  Jay Pepose; Mitchell Brigell; Eliot Lazar; Curtis Heisel; Jonah Yousif; Kavon Rahmani; Ajay Kolli; Min Hwang; Cara Mitrano; Audrey Lazar; Konstantinos Charizanis; Mina Sooch; Marguerite McDonald
Journal:  BMC Ophthalmol       Date:  2022-10-08       Impact factor: 2.086

9.  Multifocal Femto-PresbyLASIK in Pseudophakic Eyes.

Authors:  Bojan Pajic; Horace Massa; Philipp B Baenninger; Erika Eskina; Brigitte Pajic-Eggspuehler; Mirko Resan; Zeljka Cvejic
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.